Stock screenerAll disclosures →
EDGAR →
PVLA
Conviction 82HealthcareScan · Thu, Jun 25, 2026PVLA$136.48+5.11%
ResistanceSupportVol 14Insider sell3
3
5
Vol MA14 325.24K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price136.48
Change+5.11%
Gap-0.65%
Rel volume2.63×
Avg volume302.26K
Avg $ vol34.71M
SMA 20113.68
SMA 50118.94
SMA 20099.12
Price vs 50+14.75%
Price vs 200+37.69%
MA stackbullish
50/200 cross—
Supertrendup · 112.17
RSI (14)67
MACD hist3.13
MACD crossbull · 7d
Stoch %K / %D91 / 93
ADX (14)19
+DI / −DI37 / 13
RSI divergenceBullish
MACD divergence—
ATR %+5.42%
ADR %6.21%
52w high148.34
52w low20.62
From 52w high-8.00%
Above 52w low+561.88%
New 52w highNo
SqueezeOff
Bollinger width29.02%
%B1.19
Donchian pos90.63%
Donchian high140.25
Donchian low100.00
AVWAP (52w high)122.87
vs AVWAP high+11.07%
AVWAP (52w low)93.63
vs AVWAP low+45.76%
OBV trendFlat
Chaikin MF (20)0.10
Today vs 20d2.63×
Avg vol (14d)325.24K
Avg vol (20d)302.26K
Avg $ vol (20d)34.71M
Market cap1.96B
RS 3m (vs SPY)-0.55%
RS 6m (vs SPY)+22.46%
RS line new highNo
Trend template7/8
Technical rank90.8
1 week+21.18%
1 month+16.06%
3 months+13.36%
6 months+25.13%
1 year+518.68%
YTD+36.10%
P/E-46.93
P/B8.43
P/S44.85
P/FCF-77.75
EPS-3.71
Div yield—
ROE-17.96%
ROA-15.82%
Debt/Eq—
Current28.88
EV/EBITDA-47.72
Gross margin—
Net margin-95.58%
Rev growth60.18%
EPS growth-139.27%
Price target233.55
Target upside71.12%
Analyst ratingBuy
Institutional95.88%
Ent. value1.75B
Revenue14.5M
Net income-15.77M
Gross profit—
Free cash flow-25.18M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out14.34M
Employees29
ListedMon, Dec 16, 2024
Free float8.97M
Float %75.8%
Short interest2.12M
Days to cover12.3d
Short volume72.9%
Squeeze score100 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.20 vs −$0.90
Last surprise-33.3% miss
Setup gradeA
Conviction82 / 100
Pattern quality—
Tech rank90.8 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance126.24
Support100.65
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in PVLA
No recent disclosed trades by Congress in PVLA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PVLA · 3 buys · 7 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Goin Kathleen Chief Operating Officer · Common Stock · 2026-06-17 | Exercise | 2.15K | $15K | 2026-06-17 | 2026-06-22 |
Goin Kathleen Chief Operating Officer · Common Stock · 2026-06-17 | Exercise | 2.15K | $20K | 2026-06-17 | 2026-06-22 |
Goin Kathleen Chief Operating Officer · Common Stock · 2026-06-17 | Sell | 2.39K | $264K | 2026-06-17 | 2026-06-22 |
Goin Kathleen Chief Operating Officer · Common Stock · 2026-06-17 | Sell | 1.89K | $210K | 2026-06-17 | 2026-06-22 |
Goin Kathleen Chief Operating Officer · Common Stock · 2026-06-17 | Sell | 25 | $3K | 2026-06-17 | 2026-06-22 |
Goin Kathleen Chief Operating Officer · Stock Option (Right to Buy) · 2026-06-17 | Exercise | 2.15K | — | 2026-06-17 | 2026-06-22 |
Goin Kathleen Chief Operating Officer · Stock Option (Right to Buy) · 2026-06-17 | Exercise | 2.15K | — | 2026-06-17 | 2026-06-22 |
Goin Kathleen Chief Operating Officer · Common Stock · 2026-05-20 | Sell | 891 | $99K | 2026-05-20 | 2026-05-22 |
Goin Kathleen Chief Operating Officer · Common Stock · 2026-05-20 | Sell | 3.36K | $371K | 2026-05-20 | 2026-05-22 |
Goin Kathleen Chief Operating Officer · Common Stock · 2026-05-20 | Exercise | 2.15K | $15K | 2026-05-20 | 2026-05-22 |
SEC filings
EDGAR filings in PVLA · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.